Cardiol Therapeutics Inc. (CRDL) vs Sofgen Pharma S.A (PROCF)
- Cardiol Therapeutics Inc. CRDL 1.10 −4.35%
- Sofgen Pharma S.A PROCF 0.03 0.00%
Cardiol Therapeutics Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. is the larger, with a market value of $138.8M against $114.0M — 1.2× the size. Cardiol Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Sofgen Pharma S.A trades at 0.1×. Sofgen Pharma S.A has the higher net margin (9.52% vs 0.00%) and the higher return on invested capital (15.2% vs 0.00%). Across the 13 metrics below, Sofgen Pharma S.A leads on 10 and Cardiol Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | CRDL | PROCF | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 0.00% | 56.16% | 53.94% |
| Operating margin | 0.00% | 17.01% | 0.00% |
| Net margin | 0.00% | 9.52% | 0.00% |
| Free cash flow margin | 0.00% | 17.66% | 0.00% |
| Return on equity | (171.13%) | (213.06%) | (0.40%) |
| Return on assets | (124.40%) | 8.82% | (3.32%) |
| Return on invested capital | 0.00% | 15.21% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack